risk, highlighting justly that such a practice is largely scientifically unsupported. Based on their review of more than 76,000 unilateral hip and knee replacements, Kwasny and colleagues concluded that treating BMI as a categorical variable (as is commonly done) rather than the continuous variable that it is may overestimate risk for many patients and should not be used to guide policy decisions.
BMI has long been a convenient measure of presumed risk and the 1997 WHO BMI stratification [8] provided a simple way of labeling patients. Much of medicine is happier with discrete categories to cluster patients into-it's perhaps conceptually easier for the busy clinical mind than having to place patients along an open continuum. Few clinicians would question whether there is a point beyond which increasing obesity leads to a decline in predictable health outcomes and a mirrored increase in perioperative risk. But whether a single arithmetic derivation linking height-and-weight can accurately reflect this critical transition point for any individual patient is a more pertinent concern. Brutally categorizing a continuous variable is conceptually (as well as statistically) flawed, since it suggests those at the top of each category bracket are similar to those at the bottom. With respect to obesity, a BMI of 30.1 and a BMI of 34.9 both represent Class 1 obesity, despite the fact that there may be a large difference in risk between the two.
Many large (and influential) representative professional bodies have made consensus or expert panel recommendations providing guidelines regarding the use of BMI cut-offs for hip and knee replacement consideration. Indeed, the trend towards using a BMI of 40 as a cut-off is commonplace. With limited defensible evidence on clinical grounds to support such recommendations, the suggestion that these cutoffs might be driven by medico-economic decisions should be a concern, and the cut-off considered arbitrary, perhaps.
Kwasny and colleagues [7] raise many valid points that challenge the accepted dogma surrounding arthroplasty BMI cut-offs. In the context of primary hip and knee surgery, they make a convincing case that: (1) The use of BMI as a categorical variable erroneously misrepresents patient perioperative risk. (2) Even when considering BMI as a continuous variable, the assumption of risk profile linearity is unsupported. (3) BMI remains an inadequate independent prognosticator of risk for individual patients [7] , even [3] , and as such, Kwasny and colleagues [7] correctly suggest that it should not be used to inform policy decisions about surgical utilization.
I believe that BMI has often been used as a discriminatory block keeping many reasonable patients from enjoying the benefits of arthroplasty surgery.
Where Do We Need To Go?
There is an obvious need to better understand perioperative risk at obesity Class 3 levels and above. Do we need new proposed WHO levels greater than 45? Greater than 50? Perhaps we should consider abandoning BMIbased cutoffs altogether, and switch our focus towards evidence-supported, and likely far more predictive, perioperative risk profiling calculators [9] .
There is also a need to better characterize the complex relationship between BMI and other definable health variables. While the WHO-defined healthy weight BMI range is appropriate, recognizing a changing average BMI may need more emphasis, and we also need to determine with greater clarity how BMI interacts with other factors that matter in the context of arthroplasty surgery, including diabetes, coronary artery disease, and perhaps even cerebrovascular risk. While elevated body weight is certainly associated with a higher statistical likelihood of concurrent comorbidities [1, 10] (which undoubtedly inflate perioperative risk), the use of a crude arithmetic calculation linking height-and-weight as a key determinant of fitness for surgery or absolute risk is far from ideal.
Excessive body weight does have implications for lower-extremity arthroplasty performance and survivorship.
Joint reaction forces during brisk walking and simple domestic stair climbing have been calculated to be five to six times a person's body weight [6] . However, it seems more likely that aseptic loosening is driven by load (weight and usage) than BMI. For example, a fit, active, 6'6" man who weighs 260 pounds has a BMI of 30, and may be at greater risk of prosthesis loosening than a sedentary patient who is 5'4" and weighs 225 with a BMI of 39. However, we do not know this to be true, and learning more about this would help us to individualize our recommendations.
How Do We Get There?
Perhaps it's time to revisit and redefine the longstanding WHO BMI categorical levels. Further substratification of the current greater than 40 BMI group (such as Class 4 obesity = BMI 40-44.9; Class 5 obesity 45-50 BMI) will allow meaningful determination of perioperative risk. Confirmatory prospective studies of patients in these BMI ranges would better inform patient-by-patient decision-making.
Developed-world population norms are changing-69% of American adults are now considered overweight or obese [1] . Indeed, arthroplasty patients within the WHO healthy BMI range are becoming the exception, not the rule. While cumbersome initially, in an era of smartphone apps, accurate risk determinations are becoming easier to use and apply [2, 4] . The incorporation of population-specific variations such as ethnicity or known genotype, into fluid risk determination algorithms will allow further individualization of care but will require validation in comparative cohort studies [1, 5] . With the move towards genuinely patient-centric medicine, efforts to improve prospective peri-operative risk assessment seem financially and clinically well-justified.
